Investec Upgrades Synergy Health Plc to Buy (SYR)
Synergy Health Plc (LON:SYR) was upgraded by Investec from an “add” rating to a “buy” rating in a research note issued on Thursday, Stock Ratings Network reports. The firm currently has a GBX 1,140 ($18.29) price objective on the stock, down from their previous price objective of GBX 1,170 ($18.77). Investec’s price objective suggests a potential upside of 13.43% from the company’s current price.
Synergy Health Plc (LON:SYR) traded up 0.30% during mid-day trading on Thursday, hitting GBX 1008.00. 60,470 shares of the company’s stock traded hands. Synergy Health Plc has a one year low of GBX 891.95 and a one year high of GBX 1165.00. The stock’s 50-day moving average is GBX 1121. and its 200-day moving average is GBX 1092.. The company’s market cap is £589.9 million.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “sell” rating on shares of Synergy Health Plc in a research note to investors on Thursday. They now have a GBX 902 ($14.47) price target on the stock. Separately, analysts at N+1 Singer reiterated a “buy” rating on shares of Synergy Health Plc in a research note to investors on Thursday. Finally, analysts at Numis Securities Ltd initiated coverage on shares of Synergy Health Plc in a research note to investors on Wednesday, August 28th. They set an “add” rating and a GBX 1,300 ($20.86) price target on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. Synergy Health Plc presently has an average rating of “Hold” and an average price target of GBX 1,110.50 ($17.82).
Synergy Health plc delivers a range of specialist outsourced services to healthcare providers and other customers concerned with health management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.